Literature DB >> 25223264

Host recognition of Clostridium difficile and the innate immune response.

Carrie A Cowardin1, William A Petri2.   

Abstract

Clostridium difficile is a Gram-positive, spore forming bacillus and the most common cause of antibiotic-associated diarrhea in the United States. Clinical outcomes of C. difficile infection (CDI) range from asymptomatic colonization to pseudomembranous colitis, sepsis and death. Disease is primarily mediated by the action of the Rho-glucosylating toxins A and B, which induce potent pro-inflammatory signaling within the host. The role of this inflammatory response during infection is just beginning to be appreciated, with recent data suggesting inflammatory markers correlate closely with disease severity. In addition to the toxins, multiple innate immune signaling pathways have been implicated in establishing an inflammatory response during infection. In intoxication-based models of disease, inflammation typically enhances pathogenesis, while protection from infection seems to require some level of inflammatory response. Thus, the host immune response plays a key role in shaping the course of infection and a balanced inflammatory response which eradicates infection without damaging host tissues is likely required for successful resolution of disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Colitis; Inflammation; Innate immune response; Toxins

Mesh:

Substances:

Year:  2014        PMID: 25223264      PMCID: PMC4258135          DOI: 10.1016/j.anaerobe.2014.08.014

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  45 in total

1.  Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.

Authors:  Jeffrey Ng; Simon A Hirota; Olaf Gross; Yan Li; Annegret Ulke-Lemee; Mireille S Potentier; L Patrick Schenck; Akosua Vilaysane; Mark E Seamone; Hanping Feng; Glen D Armstrong; Jurg Tschopp; Justin A Macdonald; Daniel A Muruve; Paul L Beck
Journal:  Gastroenterology       Date:  2010-04-13       Impact factor: 22.682

2.  Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen.

Authors:  Mizuho Hasegawa; Takashi Yamazaki; Nobuhiko Kamada; Kazuki Tawaratsumida; Yun-Gi Kim; Gabriel Núñez; Naohiro Inohara
Journal:  J Immunol       Date:  2011-03-16       Impact factor: 5.422

Review 3.  Clostridium difficile infection: epidemiology, risk factors and management.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

4.  Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis.

Authors:  Irene Jarchum; Mingyu Liu; Lauren Lipuma; Eric G Pamer
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

Review 5.  NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

Authors:  Jurg Tschopp; Kate Schroder
Journal:  Nat Rev Immunol       Date:  2010-02-19       Impact factor: 53.106

Review 6.  Fecal bacteriotherapy for recurrent Clostridium difficile infection.

Authors:  Johan S Bakken
Journal:  Anaerobe       Date:  2009-09-22       Impact factor: 3.331

7.  Induction of intestinal Th17 cells by segmented filamentous bacteria.

Authors:  Ivaylo I Ivanov; Koji Atarashi; Nicolas Manel; Eoin L Brodie; Tatsuichiro Shima; Ulas Karaoz; Dongguang Wei; Katherine C Goldfarb; Clark A Santee; Susan V Lynch; Takeshi Tanoue; Akemi Imaoka; Kikuji Itoh; Kiyoshi Takeda; Yoshinori Umesaki; Kenya Honda; Dan R Littman
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

8.  A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins.

Authors:  Anthony Ryan; Mark Lynch; Sinead M Smith; Sylvie Amu; Hendrik J Nel; Claire E McCoy; Jennifer K Dowling; Eve Draper; Vincent O'Reilly; Ciara McCarthy; Julie O'Brien; Déirdre Ní Eidhin; Mary J O'Connell; Brian Keogh; Charles O Morton; Thomas R Rogers; Padraic G Fallon; Luke A O'Neill; Dermot Kelleher; Christine E Loscher
Journal:  PLoS Pathog       Date:  2011-06-30       Impact factor: 6.823

Review 9.  The enterotoxicity of Clostridium difficile toxins.

Authors:  Xingmin Sun; Tor Savidge; Hanping Feng
Journal:  Toxins (Basel)       Date:  2010-07-14       Impact factor: 4.546

10.  Binary toxin and death after Clostridium difficile infection.

Authors:  Sabrina Bacci; Kåre Mølbak; Marianne K Kjeldsen; Katharina E P Olsen
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

View more
  10 in total

Review 1.  Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?

Authors:  Mahmoud M Saleh; William A Petri
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

Review 2.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

3.  Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection.

Authors:  Erica L Buonomo; Carrie A Cowardin; Madeline G Wilson; Mahmoud M Saleh; Patcharin Pramoonjago; William A Petri
Journal:  Cell Rep       Date:  2016-06-23       Impact factor: 9.423

Review 4.  Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections.

Authors:  Amoe Baktash; Elisabeth M Terveer; Romy D Zwittink; Bastian V H Hornung; Jeroen Corver; Ed J Kuijper; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

5.  The C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37.

Authors:  Emily C Woods; Adrianne N Edwards; Kevin O Childress; Joshua B Jones; Shonna M McBride
Journal:  PLoS Pathog       Date:  2018-08-20       Impact factor: 6.823

6.  Prolonged Mechanical Ventilation Assistance Interacts Synergistically with Carbapenem for Clostridium difficile Infection in Critically Ill Patients.

Authors:  Shyh-Ren Chiang; Chih-Cheng Lai; Chung-Han Ho; Chin-Ming Chen; Chien-Ming Chao; Jhi-Joung Wang; Kuo-Chen Cheng
Journal:  J Clin Med       Date:  2018-08-20       Impact factor: 4.241

Review 7.  Nutrition, Microbiota and Role of Gut-Brain Axis in Subjects with Phenylketonuria (PKU): A Review.

Authors:  Elvira Verduci; Maria Teresa Carbone; Elisa Borghi; Emerenziana Ottaviano; Alberto Burlina; Giacomo Biasucci
Journal:  Nutrients       Date:  2020-10-29       Impact factor: 5.717

Review 8.  Teaching old mice new tricks: the utility of aged mouse models of C. difficile infection to study pathogenesis and rejuvenate immune response.

Authors:  Jae Hyun Shin; Sean W Pawlowski; Cirle A Warren
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 9.  Tuft Cells and Their Role in Intestinal Diseases.

Authors:  Sebastian Kjærgaard Hendel; Lauge Kellermann; Annika Hausmann; Niels Bindslev; Kim Bak Jensen; Ole Haagen Nielsen
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

Review 10.  Clostridium difficile - From Colonization to Infection.

Authors:  Holger Schäffler; Anne Breitrück
Journal:  Front Microbiol       Date:  2018-04-10       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.